China Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare), By Region (North, East, Southwest, Northwest, North East, South)
|
Major Players
|
China Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in China was valued at USD 3.48 billion in 2025 and is estimated at USD 3.57 million in 2026.
- The market size is expected to grow to USD 3.83 billion by 2032.
- Market to register a CAGR of around 1.38% during 2026-32.
- Product Shares
- Topical analgesics/anaesthetic grabbed market share of 55%.
- Competition
- More than 20 companies are actively engaged in producing analgesics in China.
- Top 5 companies acquired around 35% of the market share.
- CR Sanjiu Medical & Pharmaceutical Co Ltd, Hisamitsu Pharmaceutical Co Inc, Hainan Zambon Pharmaceutical Co Ltd, Yunnan Baiyao Group Co Ltd, Haleon China Co Ltd etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 85% of the market.
China Analgesics Market Outlook
China analgesics market size was valued at USD 3.48 billion in 2025 and is projected to grow from USD 3.57 billion in 2026 to USD 3.83 billion by 2032, exhibiting a CAGR of 1.38% during the forecast period. Growth remains moderate as demand continues to rise, though at a controlled pace, with stronger performance in some categories than others over the forecast period.
Demand is being supported by higher physical activity and domestic travel, which are increasing the use of pain relief products for muscle sprains, minor injuries, and everyday body discomfort. In this setting, analgesics linked to sports strains and office related neck and shoulder discomfort are seeing better traction. This is helping topical products stay more active than systemic fever relief products, especially as consumers use them more often in daily pain management.
By product, topical analgesics/anaesthetic lead with around 55% share, supported by strong demand for aerosol sprays and pain relief plasters. At the same time, systemic analgesics are facing pressure from weaker paediatric fever demand, excess stock, and more cautious self medication behaviour among parents. Analgesics used for fever relief are therefore growing more slowly, while topical formats continue to benefit from wider everyday use and better product positioning.
By sales channel, retail offline holds the leading position with around 85% share, as offline pharmacies continue to benefit from trusted service, broad store reach, and reliable access for urgent and routine purchases. Even though digital fulfilment and O2O delivery are expanding quickly, analgesics still sell mainly through physical outlets. At the same time, stronger packaging and paediatric safety standards are creating room for better product formats, improved trust, and more differentiated offerings across the category.

China Analgesics Market Growth DriverWider Activity Levels Support Everyday Pain Relief
The demand for topical pain relief products, particularly aerosol sprays and pain relief plasters, is being driven by increased levels of physical activity and domestic tourism in China. These products are frequently used by consumers to help relieve pain from muscle strains that occur during sports activity as well as by office workers to help relieve pain in their neck and shoulders. The increased use of topical pain relief products has kept them more widely used than oral or injectable fever reducing products and contributes to their more frequent use for day to day pain management.
There is official data to support this trend. For example, according to official Government of China sources, in 2024 there were approximately 4.84 million sports venues in China, which equated to approximately 3.0 square meters of sports venue space per person living in China. In addition, the Ministry of Culture and Tourism reported that Chinese residents took approximately 3.29 billion domestic vacation trips during the first half of 2025. Increased levels of physical activity and domestic tourism result in people having a greater chance of experiencing minor sprains and strains; therefore, there is an increased amount of demand for analgesic medications.
China Analgesics Market ChallengePrevention-Led Care Softens Fever-Relief Demand
The growth of the overall systemic analgesics market in China will be limited by the currently weaker season for children’s fever. Children’s fever products like acetaminophen and ibuprofen are experiencing slower than predicted growth due to the availability of pharmacy inventories and the ongoing process to clear surplus items in pharmacies. Parents are also increasingly monitoring self dosing to their children and are more frequently now seeking medical attention when children have higher fevers, which eliminates a need for over the counter relief medications.
This pattern fits current public health signals. Official data presented in 2025 show vaccine coverage under China’s national immunization program remains above 90%, supported by more than 456,000 vaccination service professionals by the end of 2024. China CDC’s Week 36, 2025 report also states influenza activity was low in both southern and northern provinces, with only 1 influenza like illness outbreak reported that week. This keeps pressure on paediatric fever relief sales.
Unlock Market Intelligence
Explore the market potential with our data-driven report
China Analgesics Market TrendDigital Fulfilment Reshapes Category Access
Digital and smart systems are becoming a clear trend in China’s analgesics category. Brands are using smarter production, traceability tools, automated patch lines, and faster online fulfilment to improve quality and speed. At the retail level, O2O delivery is becoming more important because consumers want quick access to fever and pain relief without waiting for store visits.
Official data supports this shift. China’s online retail sales reached 9.98 trillion yuan in January-August 2025, while online retail sales of physical goods reached 8.10 trillion yuan and accounted for 25.0% of total retail sales, according to the National Bureau of Statistics. In Beijing, more than 900 pharmacies now support online medical insurance payment for OTC medicines after 423 designated retail pharmacies were added in 2025. This is making analgesics easier to access through digital channels.
China Analgesics Market OpportunitySafer Packaging Opens Product Upgrade Room
Stronger packaging and paediatric safety requirements create a clear opportunity in China. Companies that improve child resistant formats, safer dosage delivery, and more suitable paediatric packaging can strengthen trust and align better with health policy. This also creates room for brands to refresh product design while improving safety standards in everyday household medicine use.
The policy direction is already visible. China’s national standards platform shows that the draft standard “Child resistant packaging—Requirements and testing for non reclosable packaging for pharmaceutical products” is under review under plan 20243378-T-469, with a 16 month project cycle after being issued on 3 December 2024. As safety rules become more detailed, analgesics manufacturers have more room to develop better paediatric packaging and differentiated formats.
Unlock Market Intelligence
Explore the market potential with our data-driven report
China Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the product is topical analgesics/anaesthetic, holding around 55% of the China analgesics market in value terms. This segment stays ahead because demand is rising for pain relief products used for muscle sprains, sports injuries, and everyday body discomfort. Strong interest in sports participation, domestic travel, and office related neck and shoulder pain is helping this segment maintain its leading position in the category.
Topical analgesics/anaesthetic also benefit from strong brand activity and better product positioning in the market. Products such as aerosol sprays and pain relief patches are gaining attention as practical and easy to use options for daily pain management. Their growth is further supported by stronger consumer awareness of pain care and the wider use of these products for both minor injuries and routine physical discomfort, which keeps the segment ahead over the forecast period.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the sales channel is retail offline, accounting for around 85% of the China analgesics market in value terms. Offline pharmacies provide consumers with a large distribution network, which provides them trust in their ability to purchase pain relief products. Similarly, the majority of customers are still willing to purchase on a timely basis or to make purchases on an ongoing basis from traditional places because they have access to trained pharmacy staff, and are familiar with the company name of the businesses in which they are shopping.
The majority of sales will continue to be provided by pharmacies at the present time because they have an extensive distribution network and offer more value to those that utilize their services. Leading players are working to maintain foot traffic through private label products, loyalty programmes, and added services for minor injury treatment. Although retail online is expanding quickly with O2O delivery and rapid fulfilment, retail offline continues to hold the larger share because store based buying remains the most trusted and established way to purchase analgesics in China.
List of Companies Covered in China Analgesics Market
The companies listed below are highly influential in the China analgesics market, with a significant market share and a strong impact on industry developments.
- CR Sanjiu Medical & Pharmaceutical Co Ltd
- Hisamitsu Pharmaceutical Co Inc
- Hainan Zambon Pharmaceutical Co Ltd
- Yunnan Baiyao Group Co Ltd
- Haleon China Co Ltd
- Henan Lingrui Pharm Co Ltd
- Shanghai Johnson & Johnson Pharmaceutical Ltd
- Tibet Cheezheng Tibetan Medicine Co Ltd
- Bristol-Myers Squibb (Shanghai) Trading Co Ltd
- Kowa Co Ltd
Competitive Landscape
In 2025, the analgesics market in China was led by Yunnan Baiyao Group, which strengthened its leadership through its strong portfolio in topical analgesics supported by sports-injury positioning, O2O distribution, and community-based pain management services, while Tianda Pharmaceutical (Zhuhai) Co Ltd emerged as the most dynamic competitor, driven by growth in its ibuprofen brand, with both companies benefiting from the faster expansion of topical analgesics amid weak systemic demand and increasing digitalisation of distribution channels.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- China Analgesics Market Policies, Regulations, and Standards
- China Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- China Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Region
- North
- East
- Southwest
- Northwest
- North East
- South
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- China Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- By Region- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- China Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- By Region- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- Yunnan Baiyao Group Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Haleon China Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Henan Lingrui Pharm Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Shanghai Johnson & Johnson Pharmaceutical Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Tibet Cheezheng Tibetan Medicine Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- CR Sanjiu Medical & Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Hisamitsu Pharmaceutical Co Inc
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Hainan Zambon Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Bristol-Myers Squibb (Shanghai) Trading Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Kowa Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Yunnan Baiyao Group Co Ltd
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
| By Region |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











